Viewing StudyNCT00378703



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00378703
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2006-09-19

Brief Title: Bevacizumab Sorafenib Tosylate and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Stage IV Renal Cell Cancer AJCC v7
Clear Cell Renal Cell Carcinoma
Recurrent Renal Cell Carcinoma
Keywords: